Skip to main content
Livermore
Livermore
ZHEN

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
41,608
Value
$20.7M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202641,608$20.7M<0.1%−4,787−10.3%ReducedHolders
Q1 202646,395$20.7M<0.1%+3,226+7.5%AddedHolders
Q4 202543,169$19.6M<0.1%+5,796+15.5%AddedHolders
Q3 202537,373$14.6M<0.1%−6,545−14.9%ReducedHolders
Q2 202543,918$19.6M0.1%−3,014−6.4%ReducedHolders
Q1 202546,932$22.8M0.1%+5,913+14.4%AddedHolders
Q4 202441,019$16.5M<0.1%+1,819+4.6%AddedHolders
Q3 202439,200$18.2M0.1%−490−1.2%ReducedHolders
Q2 202439,690$18.6M0.1%−707−1.8%ReducedHolders
Q1 202440,397$16.9M0.1%−263−0.6%ReducedHolders
Q4 202340,660$16.5M0.1%−605−1.5%ReducedHolders
Q3 202341,265$14.3M0.1%−356−0.9%ReducedHolders
Q2 202341,621$14.6M0.1%+1,742+4.4%AddedHolders
Q1 202339,879$12.6M0.1%+4,883+14.0%AddedHolders
Q4 202234,996$10.1M<0.1%−3,525−9.2%ReducedHolders
Q3 202238,521$11.2M0.1%+4,596+13.5%AddedHolders
Q2 202233,925$9.56M<0.1%+18,566+120.9%AddedHolders
Q1 202215,359$4.01M<0.1%+8,236+115.6%AddedHolders
Q4 20217,123$1.56M<0.1%+1,425+25.0%AddedHolders
Q3 20215,698$1.03M<0.1%+26+0.5%AddedHolders
Q2 20215,672$1.14M<0.1%−3,869−40.6%ReducedHolders
Q1 20219,541$2.05M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.